TS
BSX icon

Triglav Skladi’s Boston Scientific BSX Stock Holding History

Triglav Skladi’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
29,500
+7,500
+34% +$600K 0.13% 98
2025
Q4 		$2.1M Sell
22,000
-7,000
-24% -$686K 0.13% 93
2025
Q3 		$2.83M Hold
29,000
– – 0.19% 67
2025
Q2 		$3.11M Hold
29,000
– – 0.23% 66
2025
Q1 		$2.93M Hold
29,000
– – 0.24% 65
2024
Q4 		$2.59M Buy
+29,000
New +$2.55M 0.2% 62

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Triglav Skladi's BSX Position: Q1 2026 in Review

Triglav Skladi increased its Boston Scientific (BSX) stake by 34% in Q1 2026, buying an estimated $600K and bringing the position to 29,500 shares worth $1.85M. The position accounts for 0.13% of the portfolio, ranked #98.

Triglav Skladi first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.11M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Triglav Skladi held 29,500 shares of Boston Scientific worth $1.85M as of Q1 2026.
  • Triglav Skladi bought 7,500 Boston Scientific shares in Q1 2026, an estimated $600K.
  • Boston Scientific made up 0.13% of Triglav Skladi's portfolio in Q1 2026, its #98 holding.
  • Triglav Skladi first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Triglav Skladi's Boston Scientific position peaked at $3.11M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.